Skip to Main Content

Paper Details

Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.
Support Care Cancer
2
2022
AIMSS, Aromatase, CCDC148, Exemestane, HR, Letrozole, PPP1R14C, SUPT20H, breast cancer, candidate variants, exemestane, germline DNA, hormone receptor, imputed variant, intergenic variant, letrozole, non-metastatic breast cancer, participants, patient, patients, rs74418677, rs79048288, rs912571, taxane
Author NameAffiliation
Kelley M KidwellUniversity of Michigan School of Public Health ann arbor
Anna Maria StornioloIndiana University School of Medicine
Vered StearnsJohns Hopkins School of Medicine
  • 1 - 3

Datasets

Release 1.2